Live from the NIH registry
Studies recruiting near Savannah right now
Top 25 of 171 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi)
· Sponsor: NRG Oncology
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
St. Joseph — Savannah, Georgia (6.1 mi)
· Sponsor: Kartos Therapeutics, Inc.
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Summit Cancer Care, PC — Savannah, Georgia (6.1 mi)
· Sponsor: Pfizer
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: Children's Oncology Group
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Low Country Cancer Care — Savannah, Georgia (6.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)
Septic Shock, Sepsis
Phase 3
Interventional 46 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: Vivacelle Bio
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Low Country Cancer Care — Savannah, Georgia (6.1 mi)
· Sponsor: NRG Oncology
A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
Atopic Dermatitis
Phase 2
Interventional 160 participants sought
Atd002 52015 — Savannah, Georgia (6.1 mi)
· Sponsor: UCB Biopharma SRL
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Infant, Extremely Premature, Obstetric Labor, Premature
N/A
Observational 5,000 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: The University of Texas Health Science Center, Houston
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
CenExel iResearch, LLC — Savannah, Georgia (6.1 mi)
· Sponsor: Bristol-Myers Squibb
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
COVID-19 Infection
Phase 3
Interventional 300 participants sought
Velocity Clinical Research, Savannah — Savannah, Georgia (6.1 mi)
· Sponsor: Pfizer
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Idiopathic Hypersomnia
Phase 3
Interventional 248 participants sought
Southeast Lung Associates Research — Rincon, Georgia (18.7 mi)
· Sponsor: Harmony Biosciences Management, Inc.
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
Bluffton — Bluffton, South Carolina (23.7 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Bipolar Depression
Phase 3
Interventional 384 participants sought
CenExeli Research LLC 1 — Savannah, Georgia (6.1 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Charleston Neuroscience Institute - Bluffton (Site 124) — Bluffton, South Carolina (23.7 mi)
· Sponsor: EyeBiotech Ltd.
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Cutaneous Melanoma, Stage II
N/A
Interventional 2,998 participants sought
Nancy N and JC Lewis Cancer & Research Pavilion St. Joseph's/Candler — Savannah, Georgia (6.1 mi)
· Sponsor: Melanoma and Skin Cancer Trials Limited
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Treatment-resistant Depression (TRD)
Phase 2
Interventional 178 participants sought
Site 7141 — Savannah, Georgia (6.1 mi)
· Sponsor: Alto Neuroscience
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Phase 4
Interventional 55 participants sought
Willett Children's Hospital at Memorial University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: American Thrombosis and Hemostasis Network
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Migraine
Phase 3
Interventional 640 participants sought
Meridian Clinical Research, LLC — Savannah, Georgia (6.1 mi)
· Sponsor: Pfizer
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
Cancer
N/A
Interventional 500 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi)
· Sponsor: Eastern Cooperative Oncology Group
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 3
Interventional 286 participants sought
Memorial Health University Hospital — Savannah, Georgia (6.1 mi)
· Sponsor: Boehringer Ingelheim
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Memorial Health University Medical Center — Savannah, Georgia (6.1 mi)
· Sponsor: National Cancer Institute (NCI)
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia (6.1 mi)
· Sponsor: SWOG Cancer Research Network
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Low Country Cancer Care — Savannah, Georgia (6.1 mi)
· Sponsor: SWOG Cancer Research Network